Five-year disease-free survival in patients with tumors expressing both tumor Axl and stromal Gas6 (n = 37) was significantly worse than in the both-negative group (n = 12) (21.9% vs 51.3%, p = 0.04) (Fig. 4D). Here, GAS6 is linked to neoplasm.